Company Profiles

driven by the PitchBook Platform

Presage Biosciences

Description

Provider of a platform that discovers cancer drug combinations. The company develops a technology that allows for the direct comparison of multiple drugs or drug combinations in the same living tumor. In addition to identifying combination treatments for cancer, it ultimately intends to utilize its platform to precisely evaluate patient's unique responses to micro doses of multiple cancer drugs.

2008

Founded

PRIVATE

Status

11-50

Employees

Later Stage VC

Latest Deal Type

$22.9M

Total Amount Raised

6

Investors

Description

Provider of a platform that discovers cancer drug combinations. The company develops a technology that allows for the direct comparison of multiple drugs or drug combinations in the same living tumor. In addition to identifying combination treatments for cancer, it ultimately intends to utilize its platform to precisely evaluate patient's unique responses to micro doses of multiple cancer drugs.

Website:

www.presagebio.com

Formerly Known As

Presage Therapeutics

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Delivery

Primary Office

530 Fairview Avenue North Suite 1000 Seattle, WA 98109United States +1 (800) 530-5404
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Presage Biosciences's full profile, request a free trial.

Presage Biosciences Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Presage Biosciences Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Presage Biosciences Investors (6)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
CelgeneCorporationMinority000 0000000 0000
Clifford StocksAngel (individual)Minority000 0000000 0000
David WuAngel (individual)Minority000 0000000 0000
Denny Hill CapitalVenture CapitalMinority000 0000000 0000
National Institutes of HealthGovernment000 0000000 0000
Celgene Corporation
Clifford Stocks Angel (individual)
David Wu Angel (individual)
Denny Hill Capital Venture Capital
National Institutes of Health Government

Presage Biosciences Executive Team (3)

NameTitleBoard
Seat
Contact
Info
Nathan CaffoPresident
Richard Klinghoffer Ph.DChief Scientific Officer
Michael JacksonVice President of Finance & Administration
Nathan Caffo President
Richard Klinghoffer Ph.D Chief Scientific Officer
Michael Jackson Vice President of Finance & Administration

Presage Biosciences Board Members (3)

NameRepresentingRoleSinceContact
Info
Bradley MargusSelfBoard Member000 0000
James Olson Ph.DSelfCo-Founder & Chairman000 0000
Kenneth Nussbacher JDPresage BiosciencesBoard Member000 0000
Bradley Margus Board Member Self
James Olson Ph.D Co-Founder & Chairman Self
Kenneth Nussbacher JD Board Member Presage Biosciences
Request full access to PitchBook